Report Highlights
The global market for CT scanners was valued at $3.4 billion in 2011 and should reach nearly $3.7 billion in 2012. Total market value is expected to reach nearly $5.1 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 6.7%.
SCOPE OF STUDY
This report is a comprehensive business tool designed to provide an in-depth look at computed tomography scanners for various applications. The geographic scope of the report is global, with a special emphasis on individual regions. The report describes the industry, its relationship to the health care industry and its participants and trends for the future.
Categories discussed in the report include
- Low-slice scanners (< 64 slices).
- Medium-slice scanners (64 slices).
- High-slice scanners (>64 slices).
Applications discussed in the report include
- Oncology.
- Cardio and vascular.
- Neurology.
- Others (guided procedures, spine, chest/thorax, pelvic/abdominal).
All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2012 to 2017 and assessing the competitors and competitor market shares. For country-level breakdown of segments, only the base year 2012 and projections through 2017 are shown in the data tables, conveniently ignoring the year 2011, because the year-to-year differences are statistically insignificant.
The report also covers the ancillary market—portable/mobile CT scanners—as they represent the area of highest new growth, albeit separately. This study considers data pertaining only to new CT scanners that are commercially available and used for human medical diagnostic purposes. While some base year estimates related to refurbished equipment and system upgrades may be provided, data associated with these types of products and services are not considered in the main forecasts and historical estimates provided in the tables. Mobile/portable dedicated (e.g., extremity, ENT, etc.) and hybrid CT (i.e., PET/CT, SPECT/CT) scanners are also not considered in the main forecasts and estimates provided in this report.
ANALYST CREDENTIALS
Smruti Munshi is a research analyst who has specialized in the medical technologies space for the last five years. She focuses on monitoring and analyzing emerging trends, technologies, competitive benchmarking and market dynamics in the medical imaging industry. She has worked on several projects spanning the EMEA markets ranging from market insights, industry overviews to comprehensive marketing and technology-oriented custom consulting. Ms. Munshi has a M.S. in Biomedical Engineering and a B.S. in Instrumentation and Control Engineering.
Related Reports
Medical Ultrasound Devices: Technologies and Global Markets
The global market for medical ultrasound sensors was valued at $5.6 billion in 2010 and nearly $6 billion in 2011. The market should reach $8.1 billion in 2016 after increasing at a five-year compound annual growth rate (CAGR) of 6.3%.
Medical Imaging Technologies for Oncology Diagnostics: The Global Market
The global market for diagnostic imaging equipment for oncology reached more than $11.6 billion in 2010 and, despite the global recession, is forecast to grow to about $14.8 billion by 2015, an overall compound annual growth rate (CAGR) of 5% for 2010 through 2015.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More